New Developments in Pharmaceutical Treatments for Cystic Fibrosis

被引：1
作者：
Grasemann, Hartmut [1 ,2 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Div Resp Med, Toronto, ON M5S 1A1, Canada
[2] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5S 1A1, Canada
来源：
CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 05期
关键词：
D O I：
10.2174/138161212799315966
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：613 / 613
页数：1
相关论文
共 9 条
[1]   New Developments In Treatment After Lung Transplantation [J].
Benden, Christian ;
Danziger-Isakov, Lara ;
Faro, Albert .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :737-746
[2]   Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis [J].
Dorfman, Ruslan .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :674-682
[3]   Early In Vivo Testing to Assess New Therapeutic Interventions in CF Patients [J].
Gonska, Tanja .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :663-673
[4]   Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis [J].
Grasemann, Hartmut ;
Ratjen, Felix .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :726-736
[5]   Progress in Gene and Cell Therapy for Cystic Fibrosis Lung Disease [J].
Griesenbach, Uta ;
Alton, Eric W. F. W. .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :642-662
[6]   New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa [J].
Hofmann, Thomas .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :683-695
[7]   Identification and Validation of Hits from High Throughput Screens for CFTR Modulators [J].
Pasyk, Stan ;
Molinski, Steven ;
Yu, Wilson ;
Eckford, Paul D. W. ;
Bear, Christine E. .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :628-641
[8]   New Therapies in Cystic Fibrosis [J].
Ratjen, Felix ;
Grasemann, Hartmut .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :614-627
[9]   New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas [J].
Waters, Valerie .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) :696-725
1